Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody Response to Etanercept Liquid in RA
NCT00249041Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2005
- Primary completion
- Dec 2006
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Amgen. Started Oct 2005; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00249041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249041.